The Future of HCM Care

from Tales from the Heart · host Hypertrophic Cardiomyopathy Association / Lisa Salberg

Lisa Salberg and Dr. Michael Ayers explore the rapidly evolving world of HCM treatment, from myosin inhibitors and clinical trials to AFib management and patient-centered care. The episode also dives into advocacy, drug safety concerns, and why personalized treatment strategies matter more than ever for people living with hypertrophic cardiomyopathy. This conversation was recorded May 15, 2026.

Episode metadata supplied by the publisher feed · Published May 21, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

The Future of HCM Care

0:00 1:14:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Tales from the Heart?

This episode is 1 hour and 14 minutes long.

When was this Tales from the Heart episode published?

This episode was published on May 21, 2026.

Can I download this Tales from the Heart episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!